Non-invasive cardiac and pulmonary pressure sensing

A scalable solution to support healthcare professionals for personalised Heart Failure treatment

Intracardiac pressures as a way of understanding and managing heart failure

The SAVE Sensor System

Leveraging a novel combination of Seismic, Acoustic, Visual and Electric sensors for measuring intracardiac pressures

State-of-the-art machine learning

Built on Acorai’s proprietary datasets and data partnerships with world-leading hospitals

Handheld and portable form factor

A non-invasive format with an intuitive interface will integrate easily into daily practice

Expanding heart failure data

Accurate, absolute & actionable non-invasive intracardiac pressure monitoring

Accurate

The objective of the Acorai Heart Monitor is to offer accurate estimations of pulmonary pressure to support personalized heart failure treatment

Absolute

The Save Sensor System is a first-of-its-kind hardware architecture and machine learning with absolute intracardiac insights in mind.

Actionable

An ongoing clinical study (CAPTURE-HF) aims to confirm if the monitor can deliver actionable information equal to invasive methods.

Our phisolophy

<span data-metadata=""><span data-buffer="">Acorai is working to enable data that can alleviate healthcare burdens

Find out more about the Acorai Heart Monitor

Readmission rates & penalties

Ensuring that patients are stable prior to discharge reduced reamission rates

Length of stay

A better understanding of patient stability enables better discarge decisions

Complications

Continuous monitoring improves medication decisions and patient stability

Meet our partners

Working with world-leading partners to drive meaningful change

Cedars-Sinai is ranked #2 in the US, investing in, and supporting the growth of companies focused on improving healthcare and healthcare delivery.

Mayo Clinic Platform Accelerate invests in startups and helps develop, enhance, and test their AI models with Mayo Clinic Platform’s rich data sets.

EIC invests in companies with innovative, game-changing products, services or business models that could create new markets or disrupt existing ones.

HeartX is a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials.

Royal Brompton Hospital is the largest specialist heart & lung medical centre in the United Kingdom. Managed by Guy’s & St Thomas’ NHS Foundation Trust.

Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, technology-based companies.

Saint Luke’s Health System consists of 16 area hospitals and campuses and several primary and specialty care practices, and provides a range of inpatient

Bayer AG is a German multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world.

The Västra Götaland region works to stimulate research in healthcare in collaboration with universities and business.

Life Science Invest has so far invested in 20 life science companies. In the coming year, it is intended to invest with a focus on companies in the start-up phase.

KHP Ventures is a King’s College London, King’s College Hospital NHS Foundation Trust & Guy’s and St Thomas’ Hospital NHS Foundation Trust collaboration.

EIT Health Gold Track program helps the brightest minds to explore new ideas & find practical resources to create products & services rooted in innovation.

Saint Luke’s Health System consists of 16 area hospitals and campuses and several primary and specialty care practices, and provides a range of inpatient

Bayer AG is a German multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world.

The Västra Götaland region works to stimulate research in healthcare in collaboration with universities and business.

Life Science Invest has so far investedin 20 life science companies. In the coming year, it is intended to invest with a focus on companies in the start-up phase.

KHP Ventures is a King’s College London, King’s College Hospital NHS Foundation Trust & Guy’s and St Thomas’ Hospital NHS Foundation Trust collaboration.

EIT Health Gold Track program helps the brightest minds to explore new ideas & find practical resources to create products & services rooted in innovation.

Show More
Latest Insights

Explore our latest news and insights

Help us transform heart failure management

Follow our journey!

By entering your email, you accept our privacy policy and that we will regularly send emails with updates about Acorai. You can unsubscribe at any time via a link in the email.